GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 632 filers reported holding GLAXOSMITHKLINE PLC in Q3 2013. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $214,000 | +0.9% | 4,936 | +1.1% | 0.07% | +22.0% |
| Q1 2022 | $212,000 | -0.9% | 4,883 | +0.5% | 0.06% | -1.7% |
| Q4 2021 | $214,000 | +16.3% | 4,858 | +0.6% | 0.06% | +9.1% |
| Q3 2021 | $184,000 | -3.7% | 4,829 | +0.6% | 0.06% | -3.5% |
| Q2 2021 | $191,000 | -7.3% | 4,801 | -16.9% | 0.06% | -10.9% |
| Q1 2021 | $206,000 | -2.4% | 5,777 | +0.7% | 0.06% | -7.2% |
| Q4 2020 | $211,000 | +19.2% | 5,735 | +21.8% | 0.07% | +6.2% |
| Q3 2020 | $177,000 | -7.3% | 4,707 | +0.5% | 0.06% | -7.1% |
| Q2 2020 | $191,000 | +8.5% | 4,684 | +0.6% | 0.07% | +1.4% |
| Q1 2020 | $176,000 | -20.7% | 4,654 | -1.7% | 0.07% | -6.8% |
| Q4 2019 | $222,000 | +10.4% | 4,733 | +0.5% | 0.07% | +4.2% |
| Q3 2019 | $201,000 | +7.5% | 4,711 | +0.5% | 0.07% | +4.4% |
| Q2 2019 | $187,000 | -4.1% | 4,688 | +0.4% | 0.07% | -2.9% |
| Q1 2019 | $195,000 | +25.8% | 4,668 | +14.7% | 0.07% | +9.4% |
| Q4 2018 | $155,000 | +138.5% | 4,068 | +150.5% | 0.06% | +156.0% |
| Q3 2018 | $65,000 | +6.6% | 1,624 | +7.1% | 0.02% | +4.2% |
| Q2 2018 | $61,000 | -12.9% | 1,517 | -16.3% | 0.02% | -17.2% |
| Q1 2018 | $70,000 | +11.1% | 1,812 | +1.2% | 0.03% | +7.4% |
| Q4 2017 | $63,000 | -6.0% | 1,790 | +7.3% | 0.03% | -12.9% |
| Q3 2017 | $67,000 | +4.7% | 1,668 | +11.9% | 0.03% | -6.1% |
| Q2 2017 | $64,000 | +3.2% | 1,491 | +0.9% | 0.03% | 0.0% |
| Q1 2017 | $62,000 | +10.7% | 1,478 | +0.5% | 0.03% | +3.1% |
| Q4 2016 | $56,000 | +12.0% | 1,470 | +26.4% | 0.03% | +14.3% |
| Q3 2016 | $50,000 | 0.0% | 1,163 | +0.7% | 0.03% | +3.7% |
| Q2 2016 | $50,000 | +8.7% | 1,155 | +1.7% | 0.03% | +8.0% |
| Q1 2016 | $46,000 | +2.2% | 1,136 | +0.7% | 0.02% | +25.0% |
| Q4 2015 | $45,000 | +4.7% | 1,128 | +0.9% | 0.02% | 0.0% |
| Q3 2015 | $43,000 | -6.5% | 1,118 | +0.7% | 0.02% | -4.8% |
| Q2 2015 | $46,000 | -9.8% | 1,110 | +0.8% | 0.02% | -8.7% |
| Q1 2015 | $51,000 | +8.5% | 1,101 | +0.8% | 0.02% | +4.5% |
| Q4 2014 | $47,000 | -6.0% | 1,092 | +0.7% | 0.02% | -29.0% |
| Q3 2014 | $50,000 | +4.2% | 1,084 | +20.8% | 0.03% | -43.6% |
| Q2 2014 | $48,000 | 0.0% | 897 | +0.9% | 0.06% | +37.5% |
| Q1 2014 | $48,000 | +2.1% | 889 | +0.8% | 0.04% | 0.0% |
| Q4 2013 | $47,000 | +6.8% | 882 | +0.7% | 0.04% | -7.0% |
| Q3 2013 | $44,000 | +2.3% | 876 | +0.7% | 0.04% | -31.7% |
| Q2 2013 | $43,000 | – | 870 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |